THOMAS BRAXTON KING
CIK 1279309 · Executive Chairman · last filed 2025-09-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.74M
Companies
5
Total Filings
65
Lifetime Open-Market Net
-$577.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACHV | Executive Chairman | 315,142 | $5.52 | $1.74M | -$387.4K | 6 | 2025-09-08 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 1,583 | $0.07 | $103 | $0 | 3 | 2024-07-08 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Director | — | $1.10 | — | $0 | 4 | 2023-06-08 |
| VIVUS INC (VVUS) Delisted | Interim Chief Executive Office | — | — | — | $0 | 5 | 2020-02-24 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | President & CEO | 77,223 | — | — | -$190.5K | 46 | 2015-11-03 |
Recent Filings · Page 2 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-07 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-07 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-16 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-24 | VIVUS INC (VVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-10-29 | VIVUS INC (VVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-19 | VIVUS INC (VVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-30 | VIVUS INC (VVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-31 | VIVUS INC (VVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-21 | — | Mixed | −77,224 | $0 | |
| 2015-11-03 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | — | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.